| 173 | 6 | 8 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探究复方苦参注射液联合平消片的治疗对乳腺癌患者肿瘤标志物、细胞因子和T淋巴细胞亚群水平的影响,为乳腺癌患者的辅助治疗提供理论依据。方法:选取本院收治的100例乳腺癌患者,将患者按随机数字表法分为观察组和对照组,每组各50例,对照组患者采用AC序贯T化疗方案,观察组在AC序贯T化疗的基础上给予复方苦参注射液联合平消片的治疗。治疗前后分别检测各组乳腺癌患者肿瘤标志物、细胞因子和T淋巴细胞亚群水平。结果:治疗前两组乳腺癌患者乳腺癌肿瘤标志物水平、细胞因子水平和T淋巴细胞亚群水平的比较差异无统计学意义(P>0.05)。与治疗前相比,观察组和对照组乳腺癌患者经相关治疗后肿瘤标志物(CA153、CEA和CA125)、细胞因子(IL-4、IL-6和IL-10)降低、IFN-γ及IL-2升高,T淋巴细胞亚群(CD3+、CD4+、CD4+/CD8+)升高,CD8+降低,差异存在统计学意义(P<0.05)。与治疗后对照组相比,观察组经治疗后肿瘤标志物(CA153、CEA和CA125)、CD8+和细胞因子(IL-4、IL-6和IL-10)降低、IFN-γ和IL-2升高,T淋巴细胞亚群(CD3+、CD4+、CD4+/CD8+)升高,CD8+降低,组间比较差异存在统计学意义(P<0.05)。结论:复方苦参注射液联合平消片的治疗可降低乳腺癌患者的肿瘤标志物水平,提高细胞因子和T淋巴细胞亚群水平,对乳腺癌患者的综合治疗具有积极的临床意义。
Abstract：Objective:To investigate the influence of Compound Radix Sophorae Flavescentis Injection and Xiaoyao pill combined therapy on tumor markers,cytokines and lymphocyte subpopulations of breast cancer patients,thus provide relevant assistance on clinical therapy for breast cancer patients.Methods:A total of 170 cases of breast cancer patients treated in our hospital were selected and divided to be the observe group and control group at random,with 85 cases in each group.For patients in control group,AC chemotherapeutic project was utilized,and for patients in observe group,Compound Radix Sophorae Flavescentis Injection and Xiaoyao pill combined therapy were provided on the basis of AC chemotherapy.Tumor markers,cytokines and lymphocyte subpopulations of breast cancer patients in each group were detected before and after therapy.Re-sults:Comparison of tumor markers,cytokines and lymphocyte subpopulations levels between the two groups of breast cancer patients before therapy showed no statistical significance(P>0.05).Compared with prior therapy,the tumor markers(CA153,CEA and CYRA21-1),CD8~+and cytokines(IL-4,IL-6and IL-10)on both the two groups of breast cancer patients were dramatically decreased,while lymphocyte subpopulations(CD3+,CD4+,CD4+/CD8+),IFN-γand IL-2were significantly increased,the differences showed statistical significance(P<0.05).Conclusion:Compound Radix Sophorae Flavescentis Injection and Xiaoyao pill combined therapy significantly improved the tumor markers,cytokines and lymphocyte subpopulations of the breast cancer patients.It is of vital clinical significance for treatment on breast cancer patients.
1 Kuchenbaecker KB,Ramus SJ,Tyrer J,et al.Identification of six new susceptibility loci for invasive epithelial ovarian cancer[J].Nature Genet,2015,47(2):164-171.
2 Lawson DA,Bhakta NR,Kessenbrock K,et al.Single-cell analysisreveals a stem-cell program in human metastatic breast cancer cells[J].Nature,2015,526(7571):131-135.
3 岳璇弟,褚旭.乳腺癌患者血清多项指标与复发转移的相关性研究[J].海南医学院学报,2014,20(8):1120-1122.
4 Choi DR,Yoon SN,Kim HS,et al.A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancer[J].Cancer Chemoth Pharm,2015,75(3):639-643.
5 Wu S,Yang X,Li Y,et al.Preparation of HCPT-loaded nanoneedles with pointed ends for highly efficient cancer chemotherapy[J].Nanoscale Res Lett,2016,11(1):1-10.
6 Group EBCTC.Adjuvant bisphosphonate treatment in early breast cancer:meta-analyses of individual patient data from randomised trials[J].Lancet,2015,386(10001):1353-1361.
7 姚乐申,袁毅路,李燕,等.PinX1基因的真核表达载体构建及其在乳腺癌细胞中的表达[J].实用老年医学,2015,29(12):1000-1003.
8 Group EBCTC.Aromatase inhibitors versus tamoxifen in early breast cancer:patient-level meta-analysis of the randomised trials[J].Lancet,2015,386(10001):1341-1352.
9 Yamaguchi K,Abe H,Newstead GM,et al.Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer:comparison based on the molecular subtypes of invasive breast cancer[J].Breast Cancer,2015,22(5):496-502.
10 王越希,陈晓梅,晏军,等.Twist表达情况与乳腺癌细胞株多药耐药性的相关性研究[J].海南医学院学报,2016,22(7):632-635.
11 Easton DF,Pharoah PDP,Antoniou AC,et al.Gene-panel sequencing and the prediction of breast-cancer risk[J].New Engl J Med,2015,372(23):2243-2257.
12 Thorsen LBJ,Offersen BV,DanH,et al.DBCG-IMN:a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer[J].J Clin Oncol,2016,34(4):314-320.
13 Bangaru SD,Kozarsky PE,Lee DJ,et al.A bystander effect of lung cancer chemotherapy on chronic echinococcal disease[J].World J Surg Oncol,2015,6(4):416-420.
14 Qin Y,Chen D.Nutritional support of tumor patients with chemotherapy[J].Cell Biochem Biophys,2015,72(2):633-636.
15 Hurwitz HI,Smith DC,Pitot HC,et al.Safety,pharmacokinetics,and pharmacodynamic properties of oral DEBIO1143(AT-406)in patients with advanced cancer:results of a first-in-man study.[J].Cancer Chemoth Pharm,2015,75(4):851-859.
16 Petrylak DP,Vogelzang NJ,Budnik N,et al.Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer(MAINSAIL):a randomised,double-blind,plTebo-controlled phase 3trial[J].Lancet Oncol,2015,16(4):417-425.
17 宋涛,曾祥刚,李星宇.术前化疗对乳腺癌患者术中顺苯磺阿曲库铵肌松效应的影响[J].贵州医药,2014,38(9):822-824.
18 Tolcher AW,Patnaik A,Papadopoulos KP,et al.Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma[J].Cancer Chemoth Pharm,2015,75(1):183-189.
19 Zar ZM,Singer DR.Influx transporter variants as predictors of cancer chemotherapy-induced toxicity:systematic review and meta-analysis[J].Pharmogenomics,2016,17(10):1189-1205.
20 亓宪银,刘民杰.复方苦参注射液对肺癌术后化疗患者免疫功能的影响[J].现代肿瘤医学,2014,22(1):84-86.
21 徐丁洁,洪丽文,徐洪,等.补肾调经方、平消片对雄激素致排卵障碍模型大鼠腺垂体、卵巢影响的比较研究[J].中国中西医结合杂志,2014,34(1):87-90.
基本信息:
DOI：10.13210/j.cnki.jhmu.20161009.005
中图分类号:R737.9
引用信息:
[1]李晓莉,胡鹏涛,曹予文.复方苦参注射液联合平消片治疗乳腺癌的机制研究[J].海南医学院学报,2016,22(23):2876-2879.DOI:10.13210/j.cnki.jhmu.20161009.005.
基金信息:
河南省科技厅科技计划项目(2015FB9821)~~
2016-10-09
2016-10-09
2016-10-09